Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Cardiovascular Diseases/prevention & control"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
ObjectiveMarginalized communities shoulder a disproportionate burden of cardiovascular disease (CVD) driven by concentrated neighborhood social risk factors. We provide a case study of systems science application to address geographic CVD health disp
Externí odkaz:
https://doaj.org/article/068f0e6e57e3477e9bdd50dafc2b2a9a
Autor:
Ezra A. Amsterdam, MD, Roger S. Blumenthal, MD, FACC, FAHA, Nathan D. Wong, PhD, FACC, FAHA, FNLA
Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background The 2013 Diabetes Canada guidelines recommended routinely using vascular protective medications for most patients with diabetes. These medications included statins and angiotensin-converting enzyme inhibitors (ACEIs) or angiotensi
Externí odkaz:
https://doaj.org/article/aadfaf2bb394495b80448feab646ee6a
Autor:
Mikael Hoffmann, Peter M. Nilsson, Johan Ahlner, Björn Dahllöf, Mats Fredrikson, Roger Säljö, Karin I. Kjellgren
Publikováno v:
Scandinavian Journal of Primary Health Care, Vol 38, Iss 2, Pp 166-175 (2020)
Objective: To compare the assessments of 10-year probability by patients and their physicians of cardiovascular complications of hypertension with actual outcomes. Design: Patients with uncomplicated hypertension treated with at least one antihyperte
Externí odkaz:
https://doaj.org/article/846aa0a254d84a5487cd5e3aa9d50e9f
Publikováno v:
Revista de Saúde Pública, Vol 54 (2020)
ABSTRACT OBJECTIVE To analyze the impact of two interventions (implementation and suspension of mandatory vehicle inspection) on morbidity and mortality due to conditions related to air pollution, from 2008 to 2017. METHODS Interrupted time series (A
Externí odkaz:
https://doaj.org/article/f9a195aa7928486985b63b5ca977ab66
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rikke Søgaard, Axel Cosmus Pyndt Diederichsen, Lars M Rasmussen, Jess Lambrechtsen, Flemming H Steffensen, Lars Frost, Kenneth Egstrup, Grazina Urbonaviciene, Martin Busk, Jes S Lindholt
Publikováno v:
Søgaard, R, Diederichsen, A C P, Rasmussen, L M, Lambrechtsen, J, Steffensen, F H, Frost, L, Egstrup, K, Urbonaviciene, G, Busk, M & Lindholt, J S 2022, ' Cost effectiveness of population screening vs. no screening for cardiovascular disease : the Danish Cardiovascular Screening trial (DANCAVAS) ', European Heart Journal, vol. 43, no. 41, pp. 4392–4402 . https://doi.org/10.1093/eurheartj/ehac488
Aims A recent trial has shown that screening of men for cardiovascular disease (CVD) may reduce all-cause mortality. This study assesses the cost effectiveness of such screening vs. no screening from the perspective of European healthcare systems. Me
Autor:
Araújo, F, Caldeira, D, Aguiar, C, Antunes, JP, Cardim, N, Cunha, V, Fonseca, L, Moura, JP, Paixão-Dias, VM, Ribeiro, H, Cruz, VT, Gavina, C
Publikováno v:
Revista Portuguesa de Cardiologia.
Cardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, ho
Publikováno v:
Vascular Health and Risk Management, Vol 2016, Iss Issue 1, Pp 219-227 (2016)
Morten Krogh Christiansen, Jesper Møller Jensen, Anders Krogh Brøndberg, Hans Erik Bøtker, Henrik Kjærulf JensenDepartment of Cardiology, Aarhus University Hospital, Aarhus, DenmarkBackground: Control of cardiovascular risk factor is important in
Externí odkaz:
https://doaj.org/article/e36854a452474041a43843f8a21bc966